Skip to main content
Clinical Trials/CTRI/2021/01/030473
CTRI/2021/01/030473
Completed
未知

Development and validation of a self-administered Diabetes Drug Discontinuation (DDD) questionnaire to evaluate prevalence of treatment discontinuation among type 2 diabetes mellitus patients - Diabetes Drug Discontinuation (DDD) Study

ucknow Diabetes Study Society0 sites673 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
ucknow Diabetes Study Society
Enrollment
673
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
ucknow Diabetes Study Society

Eligibility Criteria

Inclusion Criteria

  • a)Diabetes patient who has received pharmacological (allopathic) treatment for more than one month at any time since diagnosis of diabetes, as per ADA guidelines.
  • b)Patientâ??s age at the time of giving consent should be \> 18 years
  • c)Willing to accept \& sign informed consent before data collection / documentation.

Exclusion Criteria

  • a)Patient on alternative medicine only.
  • b)Recent acute illness within one month (before the date of enrolling in the present study) requiring hospitalization.
  • c)Illiterate persons. Not able to understand and comply with instructions.
  • d)Patients unable to do self\-care, self\-administration of medication or have poor cognitive functions.

Outcomes

Primary Outcomes

Not specified

Similar Trials